You are using an outdated browser. Please upgrade your browser to improve your experience.

Tbio
EXT2
Exostosin-2

Protein Summary
Description
Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor. Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413). This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000343631
  • ENSP00000342656
  • ENSG00000151348
  • ENST00000358681
  • ENSP00000351509
  • ENST00000395673
  • ENSP00000379032
  • ENST00000533608
  • ENSP00000431173

Symbol
  • SOTV
  • SSMS
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
kinase perturbation
0.99
disease perturbation
0.83
cellular component
0.8
virus perturbation
0.76
transcription factor binding site profile
0.74


Related Tools
Target Illumination GWAS Analytics (TIGA)
TIGA scores and ranks GWAS discovered associations according to the quantity and quality of the evidence supporting the association.
GENEVA
GENEVA (GENe Expression Variance Analysis) allows you to identify RNA-sequencing datasets from the Gene Expression Omnibus (GEO) that contain conditions modulating a gene or a gene signature.
GlyGen
GlyGen is a data integration and dissemination project for carbohydrate and glycoconjugate related data.
ARCHS4
ARCHS4 provides access to gene-function predictions based on RNA-seq co-expression, and gene expression levels across cell and tissues.
IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 196.46   (req: < 5)
Gene RIFs: 63   (req: <= 3)
Antibodies: 218   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 196.46   (req: >= 5)
Gene RIFs: 63   (req: > 3)
Antibodies: 218   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 16
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0
GWAS Traits (1)
GWAS Trait
EFO ID
Study Count
SNP Count
Beta Count
Odds Ratio
Evidence (Mean Rank Score)
Provenance
balding measurement
1
1
1
77.3
GWAS Trait
EFO ID
Beta Count
Odds Ratio
Evidence (Mean Rank Score)
Provenance
balding measurement
1
77.3
Orthologs (13)
1 – 5 of 13
Species
Name
Source ID
Gene ID
OMA
EggNOG
Inparanoid
Chimp
exostosin glycosyltransferase 2
VGNC:11348
451140
Macaque
exostosin glycosyltransferase 2
715975
Mouse
MGI:108050
14043
Rat
RGD:1307707
311215
Dog
exostosin glycosyltransferase 2
VGNC:40532
475989
Species
Name
OMA
EggNOG
Inparanoid
Chimp
exostosin glycosyltransferase 2
Macaque
exostosin glycosyltransferase 2
Mouse
Rat
Dog
exostosin glycosyltransferase 2
Protein Structure (0 Structures, 1 AlphaFold Model)
RepresentationColor Scheme
AF-Q93063-F1-model_v1

AlphaFold Structures Developed by DeepMind and EMBL-EBI

Pathways (24)
Defective EXT1 causes exostoses 1, TRPS2 and CHDS (R-HSA-3656253)

Click on a row in the table to change the structure displayed.

Items per page:
1 – 5 of 10
Data Source
Name
Explore in Pharos
Explore in Source
Reactome
Defective EXT1 causes exostoses 1, TRPS2 and CHDS
Reactome
Defective EXT2 causes exostoses 2
Reactome
Disease
Reactome
Diseases associated with glycosaminoglycan metabolism
Reactome
Diseases of glycosylation
Name
Explore in Pharos
Explore in Source
Defective EXT1 causes exostoses 1, TRPS2 and CHDS
Defective EXT2 causes exostoses 2
Disease
Diseases associated with glycosaminoglycan metabolism
Diseases of glycosylation
Gene Ontology Terms (24)
Items per page:
10
1 – 7 of 7
GO Term
Evidence
Assigned by
Inferred from Direct Assay (IDA)
BHF-UCL
Inferred from Direct Assay (IDA)
BHF-UCL
Inferred from Physical Interaction (IPI)
BHF-UCL
Non-traceable Author Statement (NAS)
BHF-UCL
Non-traceable Author Statement (NAS)
BHF-UCL
Inferred from Electronic Annotation (IEA)
UniProtKB-EC
Inferred from Electronic Annotation (IEA)
UniProtKB-KW
Protein-Protein Interactions (88)
1 – 10 of 88
INVS
Tbio
Novelty: 0.00834489
p_int: 0.999988048
p_ni: 3.18e-7
p_wrong: 0.000011635
Score: 0.359
Data Source: BioPlex,STRINGDB
TTC19
Tbio
Novelty: 0.08251578
p_int: 0.999906537
p_ni: 0.000093443
p_wrong: 2e-8
Score: 0.179
Data Source: BioPlex,STRINGDB
RBFA
Tbio
Novelty: 0.1061138
p_int: 0.997134008
p_ni: 0.000025766
p_wrong: 0.002840226
Score: 0.163
Data Source: BioPlex,STRINGDB
EXT1
Tbio
Family: Enzyme
Novelty: 0.00355951
p_int: 0.995706036
p_ni: 0.004293964
Score: 0.955
Data Source: BioPlex,Reactome,STRINGDB
AFAP1
Tbio
Novelty: 0.00859495
p_int: 0.991335525
p_ni: 2.7e-8
p_wrong: 0.008664448
Score: 0.359
Data Source: BioPlex,STRINGDB
ATE1
Tbio
Family: Enzyme
Novelty: 0.01672896
p_int: 0.988848392
p_ni: 0.011151608
Data Source: BioPlex
CUX1
Tbio
Novelty: 0.00415896
p_int: 0.984977607
p_ni: 0.015022393
Score: 0.221
Data Source: BioPlex,STRINGDB
USP30
Tbio
Family: Enzyme
Novelty: 0.03427211
p_int: 0.979750387
p_ni: 0.020249612
p_wrong: 1e-9
Score: 0.183
Data Source: BioPlex,STRINGDB
PSCA
Tbio
Novelty: 0.00323778
p_int: 0.93065173
p_ni: 0.06934827
Data Source: BioPlex
NOP9
Tdark
Novelty: 2.89535198
p_int: 0.898708476
p_ni: 0.101291403
p_wrong: 1.21e-7
Score: 0.173
Data Source: BioPlex,STRINGDB
Publication Statistics
PubMed Score  196.46

PubMed score by year
PubTator Score  136.8

PubTator score by year
Amino Acid Sequence
Residue Counts
Protein Sequence
ProtVista Viewer